Gustavo A. Rosario Benitez

Array ( [id] => 7326921 [patent_doc_number] => 20040253237 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-16 [patent_title] => 'Methods of treatment of ulcerative colitis with anti-CD3 antibodies' [patent_app_type] => new [patent_app_number] => 10/729795 [patent_app_country] => US [patent_app_date] => 2003-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 16092 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20040253237.pdf [firstpage_image] =>[orig_patent_app_number] => 10729795 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5716305 [patent_doc_number] => 20060079668 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-13 [patent_title] => 'Junctional adhesion molecule splice variants' [patent_app_type] => utility [patent_app_number] => 10/536366 [patent_app_country] => US [patent_app_date] => 2003-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13311 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0079/20060079668.pdf [firstpage_image] =>[orig_patent_app_number] => 10536366 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7308610 [patent_doc_number] => 20040142363 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-22 [patent_title] => 'N-acetylglycosaminyl transferase genes' [patent_app_type] => new [patent_app_number] => 10/727684 [patent_app_country] => US [patent_app_date] => 2003-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17493 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20040142363.pdf [firstpage_image] =>[orig_patent_app_number] => 10727684 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7084022 [patent_doc_number] => 20050049402 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-03 [patent_title] => 'Antibodies directed to tumor necrosis factor and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/727155 [patent_app_country] => US [patent_app_date] => 2003-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 35817 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20050049402.pdf [firstpage_image] =>[orig_patent_app_number] => 10727155 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5784307 [patent_doc_number] => 20060204496 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-14 [patent_title] => 'Agonist antibody against heteroreceptor' [patent_app_type] => utility [patent_app_number] => 10/540643 [patent_app_country] => US [patent_app_date] => 2003-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8921 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20060204496.pdf [firstpage_image] =>[orig_patent_app_number] => 10540643 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5748355 [patent_doc_number] => 20060111287 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-25 [patent_title] => 'Acetylated protein' [patent_app_type] => utility [patent_app_number] => 10/534254 [patent_app_country] => US [patent_app_date] => 2003-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 27807 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20060111287.pdf [firstpage_image] =>[orig_patent_app_number] => 10534254 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5799300 [patent_doc_number] => 20060034833 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-16 [patent_title] => 'Single domain antibodies directed against interferron-gamma and uses therefor' [patent_app_type] => utility [patent_app_number] => 10/534345 [patent_app_country] => US [patent_app_date] => 2003-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 25181 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20060034833.pdf [firstpage_image] =>[orig_patent_app_number] => 10534345 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7462219 [patent_doc_number] => 20040166111 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-26 [patent_title] => 'Low dose methods for treating disorders in which TNFalpha activity is detrimental' [patent_app_type] => new [patent_app_number] => 10/693233 [patent_app_country] => US [patent_app_date] => 2003-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12483 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20040166111.pdf [firstpage_image] =>[orig_patent_app_number] => 10693233 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4530903 [patent_doc_number] => 07871606 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-18 [patent_title] => 'Use of stimulated peripheral-blood mononuclear cells for the treatment of cancerous diseases' [patent_app_type] => utility [patent_app_number] => 10/687913 [patent_app_country] => US [patent_app_date] => 2003-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5186 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/871/07871606.pdf [firstpage_image] =>[orig_patent_app_number] => 10687913 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7434392 [patent_doc_number] => 20040162411 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-19 [patent_title] => 'Potent T cell modulating molecules' [patent_app_type] => new [patent_app_number] => 10/682845 [patent_app_country] => US [patent_app_date] => 2003-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 19349 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 181 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20040162411.pdf [firstpage_image] =>[orig_patent_app_number] => 10682845 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7216453 [patent_doc_number] => 20040071703 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Multicomponent mscramm vaccine' [patent_app_type] => new [patent_app_number] => 10/380191 [patent_app_country] => US [patent_app_date] => 2003-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 19079 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20040071703.pdf [firstpage_image] =>[orig_patent_app_number] => 10380191 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7116245 [patent_doc_number] => 20050069546 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-31 [patent_title] => 'Educated NKT cells and their uses in the treatment of immune-related disorders' [patent_app_type] => utility [patent_app_number] => 10/676045 [patent_app_country] => US [patent_app_date] => 2003-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 29806 [patent_no_of_claims] => 140 [patent_no_of_ind_claims] => 72 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20050069546.pdf [firstpage_image] =>[orig_patent_app_number] => 10676045 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7303220 [patent_doc_number] => 20040115197 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Remedies for infant chronic arthritis-relating diseases' [patent_app_type] => new [patent_app_number] => 10/473165 [patent_app_country] => US [patent_app_date] => 2003-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12273 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20040115197.pdf [firstpage_image] =>[orig_patent_app_number] => 10473165 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7134642 [patent_doc_number] => 20040043402 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-04 [patent_title] => 'Interferon-alpha induced gene' [patent_app_type] => new [patent_app_number] => 10/450065 [patent_app_country] => US [patent_app_date] => 2003-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7533 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20040043402.pdf [firstpage_image] =>[orig_patent_app_number] => 10450065 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5912891 [patent_doc_number] => 20060127953 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-15 [patent_title] => 'Method of diagnosing osteolysis' [patent_app_type] => utility [patent_app_number] => 10/528339 [patent_app_country] => US [patent_app_date] => 2003-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 1796 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20060127953.pdf [firstpage_image] =>[orig_patent_app_number] => 10528339 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7275071 [patent_doc_number] => 20040234522 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Type I cytokine receptor TCCR' [patent_app_type] => new [patent_app_number] => 10/663158 [patent_app_country] => US [patent_app_date] => 2003-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 53509 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20040234522.pdf [firstpage_image] =>[orig_patent_app_number] => 10663158 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5850596 [patent_doc_number] => 20060233787 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Human cd3-specific antibody with immunosuppressive properties' [patent_app_type] => utility [patent_app_number] => 10/527346 [patent_app_country] => US [patent_app_date] => 2003-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 8051 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20060233787.pdf [firstpage_image] =>[orig_patent_app_number] => 10527346 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7423170 [patent_doc_number] => 20040265315 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Methods of preventing or treating T cell malignancies by administering CD2 antagonists' [patent_app_type] => new [patent_app_number] => 10/657006 [patent_app_country] => US [patent_app_date] => 2003-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 55065 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20040265315.pdf [firstpage_image] =>[orig_patent_app_number] => 10657006 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7475308 [patent_doc_number] => 20040097712 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-20 [patent_title] => 'Therapeutic human anti-IL1-R1 monoclonal antibody' [patent_app_type] => new [patent_app_number] => 10/656769 [patent_app_country] => US [patent_app_date] => 2003-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 33713 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20040097712.pdf [firstpage_image] =>[orig_patent_app_number] => 10656769 [rel_patent_id] =>[rel_patent_doc_number] =>)